Compare Faes Farma SA with Similar Stocks
Dashboard
1
High Management Efficiency with a high ROE of 14.48%
2
Company's ability to service its debt is strong with a healthy EBIT to Interest (avg) ratio of 17.27
3
Poor long term growth as Net Sales has grown by an annual rate of 0.39% over the last 5 years
4
With ROE of 4.26%, it has a Expensive valuation with a 1.93 Price to Book Value
5
Underperformed the market in the last 1 year
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
26.7%
0%
26.7%
6 Months
13.65%
0%
13.65%
1 Year
0%
0%
0.0%
2 Years
0%
0%
0.0%
3 Years
0%
0%
0.0%
4 Years
0%
0%
0.0%
5 Years
0%
0%
0.0%
Faes Farma SA for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
0.39%
EBIT Growth (5y)
28.40%
EBIT to Interest (avg)
17.27
Debt to EBITDA (avg)
0.53
Net Debt to Equity (avg)
-0.09
Sales to Capital Employed (avg)
0.32
Tax Ratio
21.53%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
14.09%
ROE (avg)
14.48%
Valuation key factors
Factor
Value
P/E Ratio
45
Industry P/E
Price to Book Value
1.93
EV to EBIT
55.16
EV to EBITDA
43.65
EV to Capital Employed
1.68
EV to Sales
8.16
PEG Ratio
2.73
Dividend Yield
309.08%
ROCE (Latest)
3.05%
ROE (Latest)
4.26%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Mildly Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
Mildly Bearish
Mildly Bullish
OBV
Mildly Bearish
Mildly Bullish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Mar'16 - YoY
Mar'16
Mar'15
Change(%)
Net Sales
56.90
51.30
10.92%
Operating Profit (PBDIT) excl Other Income
12.80
11.10
15.32%
Interest
0.30
0.00
Exceptional Items
0.00
0.00
Consolidate Net Profit
8.10
6.80
19.12%
Operating Profit Margin (Excl OI)
193.30%
175.40%
1.79%
USD in Million.
Net Sales
YoY Growth in quarter ended Mar 2016 is 10.92% vs 5.12% in Mar 2015
Consolidated Net Profit
YoY Growth in quarter ended Mar 2016 is 19.12% vs 19.30% in Mar 2015
Annual Results Snapshot (Consolidated) - Dec'25
Dec'25
Dec'24
Change(%)
Net Sales
610.50
493.60
23.68%
Operating Profit (PBDIT) excl Other Income
101.80
112.70
-9.67%
Interest
6.30
0.70
800.00%
Exceptional Items
0.00
0.00
Consolidate Net Profit
79.70
111.10
-28.26%
Operating Profit Margin (Excl OI)
119.20%
187.20%
-6.80%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2025 is 23.68% vs 9.40% in Dec 2024
Consolidated Net Profit
YoY Growth in year ended Dec 2025 is -28.26% vs 21.16% in Dec 2024
About Faes Farma SA 
Faes Farma SA
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






